Search results for "Influenza"
Influenza featured at infectious disease meeting
A summary of approvals, recalls, warnings and alerts digested by ACP Internist from the Food and Drug Administration's alerts.
https://immattersacp.org/archives/2010/01/idsa.htm
1 Jan 2010
Modeling study finds RSV vaccines cost-effective for older U.S. adults
Vaccination programs using the monovalent adjuvanted or bivalent vaccine against respiratory syncytial virus (RSV) were projected to be potentially cost-effective at a price per dose of up to $127 or up to $118, respectively, over a first RSV season.
https://immattersacp.org/weekly/archives/2023/12/05/4.htm
5 Dec 2023
Isolated flu vaccination of elderly may not decrease hospitalization or mortality rates
Vaccination programs focusing on elderly patients may require supplemental strategies focused on vaccinating children and other high-risk populations to effectively reduce morbidity and mortality, the authors wrote.
https://immattersacp.org/weekly/archives/2020/03/03/2.htm
3 Mar 2020
Heparin labeling changed, non-egg flu vaccine approved
This regulatory update covers changed labeling for heparin and approval of a flu vaccine produced using cultured animal cells.
https://immattersacp.org/archives/2013/02/fda.htm
1 Feb 2013
Flu vaccination is rarely associated with subdeltoid bursitis, study finds
Clinicians could benefit from an injection technique “tune-up” in needle placement and needle length, an editorial suggested.
https://immattersacp.org/weekly/archives/2020/06/23/6.htm
23 Jun 2020
New heart disease test, drugs for flu, weight management
This update covers a new test to predict risk of future coronary heart disease events, the first neuraminidase inhibitor for influenza, and a new GLP-1 agonist for obese people.
https://immattersacp.org/archives/2015/03/fda.htm
1 Mar 2015
Antivirals plus antibiotics may lower risk of hospitalization in some patients with influenza
Although combination antiviral and antibiotic therapy was associated with a significant reduction in respiratory hospitalization risk within 30 days compared to an antiviral alone in this study, that does not mean the combination should be widely used, the authors noted.
https://immattersacp.org/weekly/archives/2020/02/04/2.htm
4 Feb 2020
Latest COVID-19 studies show need for repeat rapid testing, targeting of antiviral prescriptions
Viral load of SARS-CoV-2 doesn't peak until the fourth day of symptoms, one study found, while other research only saw an effect of nirmatrelvir/ritonavir on death and hospitalization among those who were moderately or severely immunocompromised, not in other high-risk groups.
https://immattersacp.org/weekly/archives/2023/10/03/2.htm
3 Oct 2023
Emergency contraception drug, flu vaccines approved
Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2010/10/fda.htm
1 Oct 2010
Concomitant influenza infection associated with worse in-hospital outcomes in heart failure patients
Rates of in-hospital mortality, acute respiratory failure with and without mechanical ventilation, and acute kidney injury with and without dialysis were significantly higher in patients admitted with heart failure and influenza infection compared to admissions for heart failure alone.
https://immattersacp.org/weekly/archives/2019/01/08/4.htm
8 Jan 2019